Pseudomonas aeruginosa inhibits the growth of Scedosporium aurantiacum, an opportunistic fungal pathogen isolated from the lungs of cystic fibrosis patients

Frontiers in Microbiology

Volumn 6, Issue AUG, 2015, Pages

  Kaur, Jashanpreet ^a   Pethani, Bhavin P ^a   Kumar, Sheemal ^a   Kim, Minkyoung ^a   Sunna, Anwar ^a   Kautto, Liisa ^a   Penesyan, Anahit ^a   Paulsen, Ian T ^a   Nevalainen, Helena ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Biofilms; Co culture; Growth inhibition; Interactions; P. Aeruginosa; Phenazines; S. Aurantiacum; SCFM

Indexed keywords

YELLOW FLUORESCENT PROTEIN;

ARTICLE; BIOFILM; CELL CULTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; GENE AMPLIFICATION; GROWTH INHIBITION; IN VITRO STUDY; MICROSCOPY; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ASSAY; SCEDOSPORIUM; SCEDOSPORIUM AURANTIACUM; SEQUENCE ANALYSIS; TRANSWELL ASSAY;

EID: 84940857494     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00866     Document Type: Article

References (68)

1. Almeida, A.J., Carmona, J.A., Cunha, C., Carvalho, A., Rappleye, C.A., Goldman, W.E., et al. (2007). Towards a molecular genetic system for the pathogenic fungus Paracoccidioides brasiliensis. Fungal Genet. Biol. 44, 1387-1398. doi: 10.1016/j.fgb.2007.04.004.
2. Bakare, N., Rickerts, V., Bargon, J., and Just-Nubling, G. (2003). Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 46, 19-23. doi: 10.1046/j.1439-0507.2003.00830.x.
3. Bandara, H.M., Yau, J.Y., Watt, R.M., Jin, L.J., and Samaranayake, L.P. (2010). Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development. BMC Microbiol. 10:125. doi: 10.1186/1471-2180-10-125.
4. Ben Haj Khalifa, A., Moissenet, D., Vu Thien, H., and Khedher, M. (2011). [Virulence factors in Pseudomonas aeruginosa: mechanisms and modes of regulation]. Ann. Biol. Clin. (Paris) 69, 393-403. doi: 10.1684/abc.2011.0589.
5. Blyth, C.C., Harun, A., Middleton, P.G., Sleiman, S., Lee, O., Sorrell, T.C., et al. (2010a). Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J. Clin. Microbiol. 48, 314-316. doi: 10.1128/JCM. 01470-09.
6. Blyth, C.C., Middleton, P.G., Harun, A., Sorrell, T.C., Meyer, W., and Chen, S.C. (2010b). Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med. Mycol. 48(Suppl. 1), S37-S44. doi: 10.3109/13693786.2010.500627.
7. Boon, C., Deng, Y., Wang, L.H., He, Y., Xu, J.L., Fan, Y., et al. (2008). A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. ISME J. 2, 27-36. doi: 10.1038/ismej.2007.76.
8. Boucher, R.C. (2007). Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu. Rev. Med. 58, 157-170. doi: 10.1146/annurev.med.58.071905.105316.
9. Brand, A., Barnes, J.D., Mackenzie, K.S., Odds, F.C., and Gow, N.A. (2008). Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa. FEMS Microbiol. Lett. 287, 48-55. doi: 10.1111/j.15746968.2008.01301.x.
10. Chen, J.W., Chin, S., Tee, K.K., Yin, W.F., Choo, Y.M., and Chan, K.G. (2013). N-acyl homoserine lactone-producing Pseudomonas putida strain T2-2 from human tongue surface. Sensors (Basel) 13, 13192-13203. doi: 10.3390/s131013192.
11. Chotirmall, S.H., Greene, C.M., and McElvaney, N.G. (2010). Candida species in cystic fibrosis: a road less travelled. Med. Mycol. 48(Suppl. 1), S114-S124. doi: 10.3109/13693786.2010.503320.
12. Cimon, B., Carrere, J., Vinatier, J.F., Chazalette, J.P., Chabasse, D., and Bouchara, J.P. (2000). Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 19, 53-56. doi: 10.1007/s100960050011.
13. Coutinho, H.D., Falcao-Silva, V.S., and Goncalves, G.F. (2008). Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int. Arch. Med. 1, 24. doi: 10.1186/1755-7682-1-24.
14. Cugini, C., Morales, D.K., and Hogan, D.A. (2010). Candida albicans-produced farnesol stimulates Pseudomonas quinolone signal production in LasR-defective Pseudomonas aeruginosa strains. Microbiology 156, 3096-3107. doi: 10.1099/mic.0.037911-0.
15. Davies, J.C. (2002). Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence. Paediatr. Respir. Rev. 3, 128-134. doi: 10.1016/S1526-0550(02)00003-3.
16. Delhaes, L., Monchy, S., Frealle, E., Hubans, C., Salleron, J., Leroy, S., et al. (2012). The airway microbiota in cystic fibrosis: a complex fungal and bacterial community-implications for therapeutic management. PLoS ONE 7:e36313. doi: 10.1371/journal.pone.0036313.
17. Doring, G., Conway, S.P., Heijerman, H.G., Hodson, M.E., Hoiby, N., Smyth, A., et al. (2000). Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur. Respir. J. 16, 749-767. doi: 10.1034/j.1399-3003.2000.16d30.x.
18. Dower, W.J., Miller, J.F., and Ragsdale, C.W.;1. (1988). High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16, 6127-6145. doi: 10.1093/nar/16.13.6127.
19. Gibson, J., Sood, A., and Hogan, D.A. (2009). Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative. Appl. Environ. Microbiol. 75, 504-513. doi: 10.1128/AEM. 01037-08.
20. Gloag, E.S., Turnbull, L., Huang, A., Vallotton, P., Wang, H., Nolan, L.M., et al. (2013). Self-organization of bacterial biofilms is facilitated by extracellular DNA. Proc. Natl. Acad. Sci. U.S.A. 110, 11541-11546. doi: 10.1073/pnas.1218898110.
21. Haas, B., Kraut, J., Marks, J., Zanker, S.C., and Castignetti, D. (1991). Siderophore presence in sputa of cystic fibrosis patients. Infect. Immun. 59, 3997-4000.
22. Harrison, F. (2007). Microbial ecology of the cystic fibrosis lung. Microbiology 153, 917-923. doi: 10.1099/mic.0.2006/004077-0.
23. Harun, A., Gilgado, F., Chen, S.C., and Meyer, W. (2010). Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonisation of airways in cystic fibrosis. Med. Mycol. 48(Suppl. 1), S70-S76. doi: 10.3109/13693786.2010.515254.
24. Heath, C.H., Slavin, M.A., Sorrell, T.C., Handke, R., Harun, A., Phillips, M., et al. (2009). Population based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin. Microbiol. Infect. 15, 689-693. doi: 10.1111/j.1469-0691.2009.02802.x.
25. Heeb, S., Fletcher, M.P., Chhabra, S.R., Diggle, S.P., Williams, P., and Camara, M. (2011). Quinolones: from antibiotics to autoinducers. FEMS Microbiol. Rev. 35, 247-274. doi: 10.1111/j.1574-6976.2010.00247.x.
26. Hibbing, M.E., Fuqua, C., Parsek, M.R., and Peterson, S.B. (2010). Bacterial competition: surviving and thriving in the microbial jungle. Nat. Rev. Microbiol. 8, 15-25. doi: 10.1038/nrmicro2259.
27. Hill, J.C., and Johnson, G.T. (1969). Microbial transformation of phenazines by Aspergillus sclerotiorum. Mycologia 61, 452-467. doi: 10.2307/3757234.
28. Hogan, D.A., and Kolter, R. (2002). Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 296, 2229-2232. doi: 10.1126/science.1070784.
29. Holloway, B.W. (1955). Genetic recombination in Pseudomonas aeruginosa. J. Gen. Microbiol. 13, 572-581. doi: 10.1099/00221287-13-3-572.
30. Horre, R., Symoens, F., Delhaes, L., and Bouchara, J.P. (2010). Fungal respiratory infections in cystic fibrosis: a growing problem. Med. Mycol. 48(Suppl. 1), S1-S3. doi: 10.3109/13693786.2010.529304.
31. Inoue, H., Nojima, H., and Okayama, H. (1990). High efficiency transformation of Escherichia coli with plasmids. Gene 96, 23-28. doi: 10.1016/0378-1119(90)90336-P.
32. Jarosz, L.M., Ovchinnikova, E.S., Meijler, M.M., and Krom, B.P. (2011). Microbial spy games and host response: roles of a Pseudomonas aeruginosa small molecule in communication with other species. PLoS Pathog. 7:e1002312. doi: 10.1371/journal.ppat.1002312.
33. Jieh-Juen Yu, G.T. C. (1998). Biolistic transformation of the human pathogenic fungus Coccidioides immitis. J. Microbiol. Methods 33, 129-141. doi: 10.1016/S0167-7012(98)00046-3.
34. Kaur, J., Duan, S.Y., Vaas, L.A., Penesyan, A., Meyer, W., Paulsen, I.T., et al. (2015). Phenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs. PLoS ONE 10:e0122354. doi: 10.1371/journal.pone.0122354.
35. Kerr, J.R. (1999). Bacterial inhibition of fungal growth and pathogenicity. Microb. Ecol. Health Dis. 11, 129-142. doi: 10.1080/089106099435709.
36. Kerr, J.R., Taylor, G.W., Rutman, A., Hoiby, N., Cole, P.J., and Wilson, R. (1999). Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52, 385-387. doi: 10.1136/jcp.52.5.385.
37. Klix, V., Nowrousian, M., Ringelberg, C., Loros, J.J., Dunlap, J.C., and Poggeler, S. (2010). Functional characterization of MAT1-1-specific mating-type genes in the homothallic ascomycete Sordaria macrospora provides new insights into essential and nonessential sexual regulators. Eukaryot. Cell 9, 894-905. doi: 10.1128/EC. 00019-10.
38. Lackner, M., de Hoog, G.S., Verweij, P.E., Najafzadeh, M.J., Curfs-Breuker, I., Klaassen, C.H., et al. (2012). Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob. Agents Chemother. 56, 2635-2642. doi: 10.1128/AAC. 0591011.
39. Lackner, M., de Hoog, G.S., Yang, L., Moreno, L.F., Ahmed, S.A., Andreas, F., et al. (2014). Proposed nomenclature for Pseudallescheria, Scedosporium and related genera. Fungal Divers. 67, 1-10. doi: 10.1007/s13225-014-0295-4.
40. Laursen, J.B., and Nielsen, J. (2004). Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem. Rev. 104, 1663-1686. doi: 10.1021/cr020473j.
41. Leclair, L.W., and Hogan, D.A. (2010). Mixed bacterial-fungal infections in the CF respiratory tract. Med. Mycol. 48(Suppl. 1), S125-S132. doi: 10.3109/13693786.2010.521522.
42. Lewenza, S., Charron-Mazenod, L., Giroux, L., and Zamponi, A.D. (2014). Feeding behaviour of Caenorhabditis elegans is an indicator of Pseudomonas aeruginosa PAO1 virulence. PeerJ 2, e521. doi: 10.7717/peerj.521.
43. Lin, L., Wagner, M.C., Cocklin, R., Kuzma, A., Harrington, M., Molitoris, B.A., et al. (2011). The antibiotic gentamicin inhibits specific protein trafficking functions of the Arf1/2 family of GTPases. Antimicrob. Agents Chemother. 55, 246-254. doi: 10.1128/AAC. 00450-10.
44. Lipuma, J.J. (2010). The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23, 299-323. doi: 10.1128/CMR. 00068-09.
45. Lynch, S.V., and Bruce, K.D. (2013). The cystic fibrosis airway microbiome. Cold Spring Harb. Perspect. Med. 3:a009738. doi: 10.1101/cshperspect.a009738.
46. Ma, L., Conover, M., Lu, H., Parsek, M.R., Bayles, K., and Wozniak, D.J. (2009). Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog. 5:e1000354. doi: 10.1371/journal.ppat.1000354.
47. Manavathu, E.K., Vager, D.L., and Vazquez, J.A. (2014). Development and antimicrobial susceptibility studies of in vitro monomicrobial and polymicrobial biofilm models with Aspergillus fumigatus and Pseudomonas aeruginosa. BMC Microbiol. 14:53. doi: 10.1186/1471-2180-14-53.
48. Mavrodi, D.V., Bonsall, R.F., Delaney, S.M., Soule, M.J., Phillips, G., and Thomashow, L.S. (2001). Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J. Bacteriol. 183, 6454-6465. doi: 10.1128/JB.183.21.64546465.2001.
49. McAlester, G., O'Gara, F., and Morrissey, J.P. (2008). Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J. Med. Microbiol. 57, 563-569. doi: 10.1099/jmm.0.47705-0.
50. Mear, J.B., Kipnis, E., Faure, E., Dessein, R., Schurtz, G., Faure, K., et al. (2013). Candida albicans and Pseudomonas aeruginosa interactions: more than an opportunistic criminal association? Med. Mal. Infect. 43, 146-151. doi: 10.1016/j.medmal.2013.02.005.
51. Middleton, P.G., Chen, S.C., and Meyer, W. (2013). Fungal infections and treatment in cystic fibrosis. Curr. Opin. Pulm. Med. 19, 670-675. doi: 10.1097/MCP.0b013e328365ab74.
52. Mowat, E., Rajendran, R., Williams, C., McCulloch, E., Jones, B., Lang, S., et al. (2010). Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol. Lett. 313, 96-102. doi: 10.1111/j.1574-6968.2010.02130.x.
53. O'Sullivan, B.P., and Freedman, S.D. (2009). Cystic fibrosis. Lancet 373, 1891-1904. doi: 10.1016/S0140-6736(09)60327-5.
54. Palmer, K.L., Aye, L.M., and Whiteley, M. (2007). Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J. Bacteriol. 189, 8079-8087. doi: 10.1128/JB. 01138-07.
55. Paugam, A., Baixench, M.T., Demazes-Dufeu, N., Burgel, P.R., Sauter, E., Kanaan, R., et al. (2010). Characteristics and consequences of airway colonisation by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med. Mycol. 48(Suppl. 1), S32-S36. doi: 10.3109/13693786.2010.503665.
56. Penttilä, M., Nevalainen, H., Rättö, M., Salminen, E., and Knowles, J. (1987). A versatile transformation system for the cellulolytic filamentous fungus Trichoderma reesei. Gene 61, 155-164. doi: 10.1016/0378-1119(87)90110-7.
57. Pihet, M., Carrere, J., Cimon, B., Chabasse, D., Delhaes, L., Symoens, F., et al. (2009). Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis-a review. Med. Mycol. 47, 387-397. doi: 10.1080/13693780802609604.
58. Punt, P.J., Dingemanse, M.A., Kuyvenhoven, A., Soede, R.D., Pouwels, P.H., and van den Hondel, C.A. (1990). Functional elements in the promoter region of the Aspergillus nidulans gpdA gene encoding glyceraldehyde-3-phosphate dehydrogenase. Gene 93, 101-109. doi: 10.1016/0378-1119(90)90142-E.
59. Quinton, P.M. (1999). Physiological basis of cystic fibrosis: a historical perspective. Physiol. Rev. 79, S3-S22.
60. Rella, A., Yang, M.W., Gruber, J., Montagna, M.T., Luberto, C., Zhang, Y.M., et al. (2012). Pseudomonas aeruginosa inhibits the growth of Cryptococcus species. Mycopathologia 173, 451-461. doi: 10.1007/s11046-011-9494-7.
61. Ruiz-Diez, B., and Martinez-Suarez, J.V. (1999). Electrotransformation of the human pathogenic fungus Scedosporium prolificans mediated by repetitive rDNA sequences. FEMS Immunol. Med. Microbiol. 25, 275-282. doi: 10.1111/j.1574-695X. 1999.tb01352.x.
62. Sibley, C.D., Rabin, H., and Surette, M.G. (2006). Cystic fibrosis: a polymicrobial infectious disease. Future Microbiol. 1, 53-61. doi: 10.2217/17460913.1.1.53.
63. Singh, P.K., Schaefer, A.L., Parsek, M.R., Moninger, T.O., Welsh, M.J., and Greenberg, E.P. (2000). Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762-764. doi: 10.1038/35037627.
64. Tang, H., Kays, M., and Prince, A. (1995). Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63, 1278-1285.
65. Te'o, V.S., Bergquist, P.L., and Nevalainen, K.M. (2002). Biolistic transformation of Trichoderma reesei using the Bio-Rad seven barrels Hepta Adaptor system. J. Microbiol. Methods 51, 393-399. doi: 10.1016/S0167-7012(02)00126-4.
66. Te'o, V.S., Cziferszky, A.E., Bergquist, P.L., and Nevalainen, K.M. (2000). Codon optimization of xylanase gene xynB from the thermophilic bacterium Dictyoglomus thermophilum for expression in the filamentous fungus Trichoderma reesei. FEMS Microbiol. Lett. 190, 13-19. doi: 10.1111/j.1574-6968.2000.tb09255.x.
67. Thornton, J.A. (2015). Splicing by overlap extension PCR to obtain hybrid DNA products. Methods Mol. Biol. doi: 10.1007/7651_2014_182 [Epub ahead of print].
68. Wilson, R., Sykes, D.A., Watson, D., Rutman, A., Taylor, G.W., and Cole, P.J. (1988). Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 56, 2515-2517.